Myrcludex B

Ask supplier a question | View on supplier's website

Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide.

Supplier	BOC Sciences
Product #	BAT-010104
Pricing	Inquire
Cas	2012558-47-1
Molecular Weight	5398.95
Molecular Formula	C248H355N65O72

Feedback